Course Outcome (COs) B. Pharm-4th Semester
At the end semester, student will able to | |
BP805ET.1 | Identify an ensure drug safety through monitoring, reporting, risk management and understanding the application of terminologies |
BP805ET.2 | Classify the drug and disease classification system are essential for organizing medical knowledge enabling targeted and coding ensure reporting and analysis in pharmacovigilance. |
BP805ET.3 | Determine the vaccine safety, surveillance ensure monitoring, detection, and prevention of adverse events. |
BP805ET.4 | Examine safety data generation is vital for informed decision making and risk managements. |
BP805ET.5 | Analyze pharmacogenomics help personalize treatments, reducing adverse drug reaction and risk. |
CO-PO Pharmacovigilance (BP805ET)
COs | PO1 | PO2 | PO3 | PO4 | PO5 | PO6 | PO7 | PO8 | PO9 | PO10 | PO11 |
BP805ET.1 | 3 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 3 | 2 | 3 |
BP805ET.2 | 3 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 3 | 2 | 3 |
BP805ET.3 | 3 | 1 | 2 | 1 | 1 | 3 | 3 | 2 | 3 | 3 | 3 |
BP805ET.4 | 3 | 2 | 2 | 2 | 1 | 3 | 3 | 2 | 3 | 2 | 3 |
BP805T.5 | 3 | 2 | 2 | 1 | 1 | 3 | 3 | 2 | 3 | 2 | 3 |
BP805ET | 3 | 2 | 2 | 1 | 1 | 3 | 3 | 2 | 3 | 2 | 3 |
Average | 3 | 2 | 2 | 1 | 1 | 3 | 3 | 2 | 3 | 2 | 3 |
*Correlation level 1, 2 or 3 is as mentioned below:
- Slight (Low) = 1;
- Moderate (medium) = 2;
- Substantial (high) = 3
Submitted By -Priyanka